Position in GLSI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$716,441
+$162,221 QoQ
Shares Held
29,827
+13.1% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 66%
Shared 0%
None 34%
Common Shares in GLSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,425,093,222 across 521 Biotechnology names. GLSI ranks #273 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in GLSI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $716,441 | 29,827 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $554,220 | 26,379 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $86,771 | 8,721 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $106,716 | 11,766 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $91,076 | 9,547 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $154,680 | 13,774 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $244,733 | 17,031 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $121,733 | 7,053 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $124,224 | 6,230 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $2,945 | 280 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $2,475 | 280 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $7,300 | 757 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $98,223 | 7,123 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $132,588 | 8,723 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $320,637 | 35,235 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $619,916 | 73,190 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $425,890 | 21,707 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $879,721 | 36,158 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $27,229 | 697 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $377,540 | 8,401 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $157,563 | 4,622 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $138,694 | 3,803 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||